The preparative regimen will consist of : Fludarabine 30mg/m2 IV Days -6, -5, -4, -3, -2 Busulfan 3.2mg/kg IV Days -6, -5, -4, -3 Total body irradiation (TBI) 4Gy Day -1 or Fludarabine 30mg/m2 I

2 trials

Sponsors

JSCT

Conditions

ALL,AML,MDS,CML,NHL,MMhematologic malignancies

Unknown Phase

A phase II study of haploidentical transplantation with post-transplantation cyclophosphamide following myeloablative conditioning

Active, not recruitingJPRN-UMIN000014406

JSCTALL,AML,MDS,CML,NHL,MM

Start: 2014-08-01Target: 38Updated: 2026-06-29

A phase II study of haploidentical transplantation with post-transplantation cyclophosphamide following myeloablative conditioning

Active, not recruitingJPRN-UMIN000020655

JSCThematologic malignancies

Start: 2016-04-01Target: 42Updated: 2026-06-29